Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Net Income Attributable to Noncontrolling Interests (2013 - 2015)

Updated

Kazia Therapeutics' Net Income Attributable to Noncontrolling Interests was $1,336 in FY2024 (year ended Dec 31, 2024).

Analysis

Kazia Therapeutics (KZIA) Net Income Attributable to Noncontrolling Interests (2013 - 2015) Analysis & Trends

From FY2009 onward, Kazia Therapeutics has reported Net Income Attributable to Noncontrolling Interests for 9 fiscal years.

  • The FY2024 figure marks the highest annual Net Income Attributable to Noncontrolling Interests in data going back to FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCI Net Income (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 2.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 2.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -1.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 10.00 Mn
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 10, 2015 123,957.20
Dec 31, 2014 86,743.76
Dec 31, 2013 13.58 Mn
API Access

Kazia Therapeutics Net Income Attributable to Noncontrolling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=KZIA&period=max&api_key=YOUR_API_KEY